Researchers from Karolinska Institutet have shown a link between use of medication for ADHD and a reduced risk of premature death. The risk of death due to unnatural causes, such as accidents and overdoses, can be reduced ...
Mar 12, 2024
1
40
Thrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonstrate improved clinical outcomes as compared to placebo, according to a recent trial published in the ...
Mar 8, 2024
0
11
A new collaborative study discloses the discovery and application of a new therapeutic strategy to target the multidrug-resistant bacterium Salmonella enterica in vivo, with promising results. The results were published in ...
Mar 7, 2024
0
40
Traumatic injuries to the peripheral nervous system are a leading cause of disability, especially in patients with proximal peripheral nerve injury. It's hard to regenerate and regain normal function in a short period, and ...
Mar 7, 2024
0
57
Spinal muscular atrophy, or SMA, is the leading genetic cause of infant death. Less than a decade ago, Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer showed this brutal disease can be treated by tweaking a ...
Mar 6, 2024
0
8
Harnessing a pervasive type of cellular messenger shows early experimental promise as a routine way of sampling and monitoring the body's response to prescription drug exposure.
Mar 5, 2024
0
15
Researchers at UCL and UCLH have successfully completed the first trial of a therapy designed to restore hearing loss. The REGAIN trial, the results of which were published in Nature Communications, was the first study of ...
Mar 5, 2024
0
95
Drug discovery can be a frustrating process of trial and error. Scientists using fragment-based drug discovery link fragments of different molecules together to create a more potent drug but may not know whether a compound ...
Feb 28, 2024
0
10
A doctor at the Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, in Philadelphia, found that a patient at the center had experienced a false positive urine test after taking empagliflozin, an SGLT2 ...
The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving UCL researchers.
Feb 27, 2024
0
28
